Intraocular Lymphoma - 18 Studies Found
Terminated |
: PXD101 and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma :
: |
Completed |
: PXD101 and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas :
|
Completed |
: MS-275 and Isotretinoin in Treating Patients With Metastatic or Advanced Solid Tumors or Lymphomas :
|
Terminated |
: MDX-010 in Treating Patients With Recurrent or Refractory Lymphoma :
: |
Completed |
: Bendamustine Hydrochloride, Etoposide, Dexamethasone, and Filgrastim For Peripheral Blood Stem Cell Mobilization in Treating Patients With Refractory or Recurrent Lymphoma or Multiple Myeloma :
: |
Completed |
: Cilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or Lymphoma :
: |